Kainos Group plc Board Committee Membership (2353P)
May 24 2018 - 10:08AM
UK Regulatory
TIDMKNOS
RNS Number : 2353P
Kainos Group plc
24 May 2018
24 May 2018
Kainos Group plc
("Kainos" or "the Company")
Board Committee Membership
In accordance with Listing Rule 9.6.11(3), the Board of
Directors of the Company announce that, with effect from 01 June
2018, Dr John Lillywhite (Company Chair) will step down as a member
of both the Remuneration Committee and the Audit and Risk
Committee.
Dr Lillywhite will continue to serve as both Chair of the
Nomination Committee and as Company Chair.
The composition of the Remuneration Committee following Dr
Lillywhite's step down will be Mr Tom Burnet (independent
Non-Executive Director) as Chair of the Remuneration Committee and
Mr Chris Cowan (independent Non-Executive Director) as a member of
the Remuneration Committee and continues to be compliant with the
UK Corporate Governance Code.
The composition of the Audit and Risk Committee following Dr
Lillywhite's step down will be Mr Andy Malpass (independent
Non-Executive Director & SID) and Mr Cowan as a member of the
Audit and Risk Committee and continues to be compliant with the UK
Corporate Governance Code.
The composition of the Nominations Committee will continue as
is, without any change.
- ENDS -
For further information,
please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive
Officer
Richard McCann, Chief Financial
Officer
Investec Bank plc +44 20 7597 4000
Andrew Pinder / Patrick
Robb
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and
Digital Platforms.
The Group's Digital Services include full lifecycle development
and support of customised Digital Services for government and
commercial customers. Kainos is also the largest boutique partner
for Workday Inc. ('Workday') in Europe, responsible for
implementing Workday's innovative Software-as-a-Service (SaaS)
platform for enterprise customers.
The Group's Digital Platforms comprise specialised digital
products in the mobile healthcare and automated testing arenas.
Evolve Electronic Medical Records ('EMR') is the market leading
product for the digitisation of patient notes in the Acute sector
of the NHS; Evolve Integrated Care ('IC') is a SaaS-based
integrated care platform for the NHS and international healthcare
providers; and Smart is an automated testing platform for Workday
customers.
Kainos employs approximately 1,100 staff and contractors across
eleven offices in Europe and the USA, working interchangeably
across its Services and Platforms businesses.
Kainos is listed on the London Stock Exchange (KNOS). For
further information, please visit www.kainos.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFKQDKQBKDPPB
(END) Dow Jones Newswires
May 24, 2018 10:08 ET (14:08 GMT)
Kainos (LSE:KNOS)
Historical Stock Chart
From Apr 2024 to May 2024
Kainos (LSE:KNOS)
Historical Stock Chart
From May 2023 to May 2024